Tobacco quitting support for people living with HIV in Kisumu County, Kenya
Official title: Integrating tobacco use cessation into HIV Care and Treatment in Ministry of Health Facilities in Kisumu County, Kenya
Funded at University of California, San Francisco · NIH-11174528 · Data updated 2026-11-12
This project brings tobacco‑cessation help into HIV clinics so people living with HIV in Kisumu can get counseling and support to quit tobacco.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California, San Francisco NIH-funded |
| Lab location | 1 site (San Francisco, United States) |
| Project start | September 16, 2021 |
| Project end | August 31, 2026 |
| Funding year | 2025 |
| Award (this year) | $1,006,744 |
| NIH project number | 5U01CA261620-05 |
| Project ID | NIH-11174528 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults living with HIV who currently use tobacco and receive care at participating Ministry of Health HIV clinics in Kisumu County, Kenya.
✕Less likely to help
People who do not use tobacco or who do not attend the participating clinics are unlikely to be able to take part or benefit from this project.
What this research studies
If you get HIV care at participating clinics, staff will ask about tobacco use and offer treatment following Kenya's national tobacco‑cessation guidelines. Clinic teams will be trained to provide brief counseling, referral, and possible medication options, and they will follow up during routine HIV visits. The program is being rolled out through existing Ministry of Health HIV clinics supported by the FACES partnership. Researchers will track how many people accept support and whether they are able to stop using tobacco over time.
Why it matters
Potential benefit: If successful, this work could help people living with HIV quit tobacco and lower their risk of tobacco‑related illness and death.
How similar studies have gone: Clinic‑based tobacco cessation programs have helped people quit in other settings, but implementing guideline‑based cessation within Kenyan HIV clinics is relatively new.
Where this research is happening
-
University of California, San Francisco
San Francisco, United States Active
Researchers
- Principal investigator: Bialous, Stella Aguinaga — University of California, San Francisco
- Study coordinator: Bialous, Stella Aguinaga
Related research
Other NIH-funded projects on the same topics.
-
Phone text program to help people with HIV in Uganda and Zambia stop smoking
This program uses tailored text messages and nicotine patches to help people living with HIV in Uganda and Zambia quit tobacco.
-
Helping people living with HIV in Uganda and Zambia quit smoking using phone-based support.
This study is testing a helpful phone program that sends supportive text messages to people living with HIV in Uganda and Zambia to help them quit smoking, comparing it to regular care like advice and nicotine patches.
-
Helping people with HIV quit tobacco in Kenya
This study is testing a new way to help people living with HIV in Kenya quit smoking by adding support programs right into their regular HIV care, making it easier for them to stop using tobacco and improve their health.
-
Ending Tobacco Use with a Smartphone Program for Cambodian People Living with HIV/AIDS
A smartphone-based quit-smoking program designed for people living with HIV/AIDS in Cambodia to help reduce tobacco use alongside HIV treatment.
-
Optimizing lung cancer care with smart tools for prevention, early detection, treatment, and survivorship
A U01 grant using AI and biomarkers to improve lung cancer prevention, screening, treatment, and survivorship care for people at risk or living with lung cancer.
-
How deforestation affects alcohol and tobacco use in Indonesia
This project looks at whether forest loss in Indonesia is linked to changes in people's tobacco and alcohol use across different places and years.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.